Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 0000-0002-9157-3730 cql: author exact 802001428865

Add to list
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu Spaas (UGent) , Nora Sundahl, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2023) JAMA ONCOLOGY. 9(9). p.1205-1213
Add to list
- Journal Article
- A1
- open access
Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Malaïka Van der Linden (UGent) , Bram Van Gaever (UGent) , Lennart Raman, Karim Vermaelen (UGent) , Ingel Demedts (UGent) , Veerle Surmont (UGent) , Ulrike Himpe, Yolande Lievens (UGent) , Liesbeth Ferdinande (UGent) , Franceska Dedeurwaerdere, et al.

(2022) CANCERS. 14(8).
Add to list
- Journal Article
- A2
- open access
Neurocognitive functioning following lung cancer treatment : the PRO-Long study

Lotte van der Weijst (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) and Wim Schrauwen (UGent)

(2022) TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY. 21. p.36-40
Add to list
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der Weijst, Miguel E. Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, et al.

(2022) LUNG CANCER. 166. p.228-241
Add to list
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Lotte van der Weijst, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 176. p.127-137
Add to list
- Conference Paper
- C3
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu Spaas (UGent) , Nora Sundahl, Sylvie Rottey (UGent) , VIBEKE KRUSE (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Piet Dirix, Veerle Surmont (UGent) , Yolande Lievens (UGent) , Robin Van den Begin, et al.

(2021) ESTRO 2021, Abstracts. 161(S1). p.S490-S491
Add to list
- Journal Article
- A1
- open access
Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study

Lotte van der Weijst (UGent) , Veerle Surmont (UGent) , Wim Schrauwen (UGent) and Yolande Lievens (UGent)

(2021) FRONTIERS IN ONCOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Lennart Raman, Malaïka Van der Linden (UGent) , Kim Van der Eecken (UGent) , Karim Vermaelen (UGent) , Ingel Demedts, Veerle Surmont (UGent) , Ulrike Himpe, Franceska Dedeurwaerdere, Liesbeth Ferdinande (UGent) , Yolande Lievens (UGent) , et al.

(2020) GENOME MEDICINE. 12(1).
Add to list
- Journal Article
- A1
- open access
Health-related quality of life in advanced non-small cell lung cancer : a methodological appraisal based on a systematic literature review

Lotte van der Weijst (UGent) , Yolande Lievens (UGent) , Wim Schrauwen (UGent) and Veerle Surmont (UGent)

(2019) FRONTIERS IN ONCOLOGY. 9.
Add to list
- Conference Paper
- C3
Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Lotte van der Weijst (UGent) , Renée Bultijnck (UGent) , Axel Van Damme, Marc Van Eijkeren (UGent) , Veerle Surmont (UGent) and Yolande Lievens (UGent)

(2019) RADIOTHERAPY AND ONCOLOGY. 133(suppl. 1). p.S103-S103
Add to list
- Conference Paper
- C3
Real-world neurocognitive function in lung cancer : initial results of the PRO-Long study.

Lotte van der Weijst (UGent) , Veerle Surmont (UGent) , Wim Schrauwen (UGent) and Yolande Lievens (UGent)

(2019) JOURNAL OF THORACIC ONCOLOGY. 14(10). p.S603-S603
Add to list
- Conference Paper
- C3
Health-related quality of life reporting in lung cancer trials : a methodological appraisal

Lotte van der Weijst (UGent) , Veerle Surmont (UGent) , Wim Schrauwen (UGent) and Yolande Lievens (UGent)

(2017) RADIOTHERAPY AND ONCOLOGY. 123(suppl. 1). p.S354-355
Add to list
Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction

PATRICK BERKOVIC (UGent) , Leen Paelinck (UGent) , Akos Gulyban, Marc Van Eijkeren (UGent) , Veerle Surmont (UGent) , Yolande Lievens (UGent) and Katrien Vandecasteele (UGent)

(2017) ACTA ONCOLOGICA. 56(11). p.1656-1658
Add to list
Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?

Lotte van der Weijst (UGent) , Veerle Surmont (UGent) , Wim Schrauwen (UGent) and Yolande Lievens (UGent)

(2017) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 119. p.40-49
Add to list
- Conference Paper
- C3
Quality of life in locally-advanced non-small cell lung cancer patients : a systematic review

Lotte van der Weijst (UGent) , Wim Schrauwen (UGent) , Veerle Surmont (UGent) and Yolande Lievens (UGent)

(2016) RADIOTHERAPY AND ONCOLOGY. 119(suppl. 1). p.S581-S581
Add to list
Unresectable stage III non-small-cell lung cancer : have we made any progress?

CAROLIEN DE TOLLENAERE (UGent) , Yolande Lievens (UGent) , Katrien Vandecasteele (UGent) , Karim Vermaelen (UGent) and Veerle Surmont (UGent)

(2015) WORLD JOURNAL OF RESPIROLOGY. 5(2). p.140-151
Add to list
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?

PATRICK BERKOVIC (UGent) , Leen Paelinck (UGent) , Yolande Lievens (UGent) , Akos Gulyban, Bruno Goddeeris (UGent) , CRISTINA DERIE (UGent) , Veerle Surmont (UGent) , Wilfried De Neve (UGent) and Katrien Vandecasteele (UGent)

(2015) ACTA ONCOLOGICA. 54(9). p.1438-1444
Add to list
- Journal Article
- A2
- open access
EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression

KATRIJN VAN ASSCHE (UGent) , Liesbeth Ferdinande (UGent) , Yolande Lievens (UGent) , Katrien Vandecasteele (UGent) and Veerle Surmont (UGent)

(2014) FRONTIERS IN ONCOLOGY. 4.

Academic Bibliography

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Neurocognitive functioning following lung cancer treatment : the PRO-Long study

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Health-related quality of life in advanced non-small cell lung cancer : a methodological appraisal based on a systematic literature review

Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Real-world neurocognitive function in lung cancer : initial results of the PRO-Long study.

Health-related quality of life reporting in lung cancer trials : a methodological appraisal

Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?

Quality of life in locally-advanced non-small cell lung cancer patients : a systematic review

Unresectable stage III non-small-cell lung cancer : have we made any progress?

Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?

EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression

Contents

Support

Contact